Distribution Function
Vessel and Blood Flow Characteristics
Effects of Gravity on Vascular Pressures
Perfusion Zones of the Lung: Zone 1
PALVEOLAR > PARTERIAL > PVENOUS
No flow conditions, vessel collapsed shut
In Zone I regions, the pressure of alveolar gas is greater than the arterial pressure perfusing the lung. In this case the pulmonary capillaries will be compressed by the alveolar gas pressure and will close off. There will be no flow. This is alveolar dead space.
Perfusion Zones of the Lung: Zone 2
Recruitment: Flow depends upon arterio-alveolar pressure difference
In Zone II regions, the arterial pressure is greater than alveolar so that there is some flow. Both are greater than venous pressure. Because of the collapsible nature of the vessels, this acts as a Starling Resistor and the pressure determining the amount of flow is the difference between arterial pressure and alveolar pressure. Venous pressure does not offer a relevant back pressure and so does not oppose flow. It is almost like a waterfall where the water pressure below the waterfall has no impact on flow over the cascade.
Perfusion Zones of the Lung: Zone 3
Continuous flow: Flow depends on arterio-venous pressure difference
This is the way things usually work. The pressures at either end of the system determine flow; i.e. the difference between the pulmonary artery and the left atrium.
Pulmonary vascular resistance is the sum of large (arteries) and small (capillary) vessels.
The large vessels that are extra-pulmonary are not exposed to alveolar pressures and are distended at the apex due to the negative pleural pressure (reducing resistance at apex), while large vessels at the base are compressed (increasing resistance at base). This counteracts the distribution of capillary resistance (greater at apex)
Passive Effects on Pulmonary vascular Resistance
Vascular Pressures and Exercise
•Increased cardiac output will raise pulmonary arterial pressure. This will then reduce the pulmonary vascular resistance in two ways:
•This reduction in resistance will allow a reduction in pulmonary pressures. Thus, the system can accommodate dramatic increases in cardiac output with little or no change in pulmonary artery pressures.
Vascular Pressures adn Shock
•Decreased cardiac output will drop pulmonary arterial pressures. This will increase pulmonary vascular resistance in two ways:
•This increase in resistance will maintain perfusion pressure. However, alveoli in Zone 1 regions are not perfused and are dead space ventilation. Thus, physiologic dead space will increase as shock worsens and cardiac output decreases.
Lung Volume and Extra-Alveolar Vessels
Lung Volume and Intra-Alveolar Vessels
Intra and Extra Alveolar Vessels
The intra-alveolar vessels are in series with the extra-alveolar vessels. Thus, the change in the total pulmonary vascular resistance with lung volume will be equal to the sum of the two types of vessel.

This graph demonstrates three concepts:
Intra-alveolar vessels have the lowest resistance at residual volume.
Extra-alveolar vessels have the lowest resistance at total lung capacity.
The total pulmonary vascular resistance is lowest at FRC; i.e. in the range of lung volume that we normally maintain.
Active Regulation of Pulmonary Vascular Resistance
Neural Control
Local Control
Alveolar Hypoxia
Humoral Control
•vasoactive substances can have an impact on smooth muscle tone in the pulmonary vasculature
Pulmonary Hypertension
Pulmonary hypertension means high pressure in the pulmonary circulation which is almost always due to a high pulmonary vascular resistance. It can occur acutely due to lung disease such as hyaline membrane disease, acute respiratory distress syndrome, or due to a pulmonary embolism (a blood clot blocking the pulmonary arterial system)
Chronic Pulmonary Hypertension
•Chronic pulmonary hypertension is usually divided into arterial, venous, hypoxic, thromboembolic, or miscellaneous. It may be idiopathic in nature or secondary to lung disease, chronic hypoxia due to obstructive sleep apnea, vasculitis due to auto-immune disease, drug toxicity, left sided heart disease, metabolic conditions, and some malignancies.
The key issue is that chronically increased pulmonary vascular resistance and pressures can lead to right sided heart failure, intrapulmonary shunting, and even pulmonary hemorrhage.
Management of Chronic Pulmonary Hypertension
The management consists of treating any condition leading to the problem. In idiopathic disease pulmonary vasodilators (epoprostenol, sildenafil, bosentan) and anti-thrombosis drugs are used. In most cases, oxygen is used to maintain high arterial saturations in the hope that these represent high alveolar oxygen levels which will cause pulmonary vasodilation. Unfortunately, cardiotonic medications such as digoxin often have no impact on the right sided heart failure and can potentially increase pulmonary vascular resistance.
Management of Acute Pulmonary Hypertension
In acute pulmonary hypertension often mechanical ventilation is used to cause hyperventilation with an increase in blood ph leading to pulmonary vasodilation. This may be combined with giving inspired nitric oxide to further dilate the well-ventilated lung.
Fluid Movement Through the Lung - Starling’s Law
Net fluid out = K[(Pc - Pi) - σ(πc - πi)] = 3 mmHg
Thus, there is a continuous small leak of fluid out of the capillary into the interstitium of the lung. This must be cleared by the lymphatics.
The lymphatics are very efficient at pumping this fluid out of the lung and can increase the lymph flow by 10-fold if needed.